Back
BioCardia, Inc. 10K Form
Sell
38
BCDA
BioCardia, Inc.
Last Price:
$1.25
Seasonality Move:
-9.27%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive BCDA News And Ratings
See the #1 stock for the next 7 days that we like better than BCDA
BCDA Financial Statistics
Sales & Book Value
| Annual Sales: | $58K |
|---|---|
| Cash Flow: | $-1.7M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $0.25 |
| Price / Book: | 5.13 |
Profitability
| EPS (TTM): | -1.72520 |
|---|---|
| Net Income (TTM): | $-8.5M |
| Gross Margin: | $-372K |
| Return on Equity: | -1519.03% |
| Return on Assets: | -209.38% |
BioCardia, Inc. Earnings Forecast
Key BioCardia, Inc. Financial Ratios
-
The Gross Profit Margin over the past 29 years for BCDA is -641.38%.
-
The Selling, General & Administrative Expenses for BCDA have been equal to 6,331.03% of Gross Profit Margin.
-
The Research & Development expenses have been 7,448.28% of Revenue.
-
The Net Earning history of BCDA is -13,700.00% of Total Revenues.
-
Per Share Earnings over the last 29 years have been positive in 17 years.
BioCardia, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | BCDA |
| Website: | biocardia.com |
Debt
| Debt-to-Equity Ratio: | 0.24 |
|---|---|
| Current Ratio: | 1.62 |
| Quick Ratio: | 1.6 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
BCDA Technical Analysis vs Fundamental Analysis
Sell
38
BioCardia, Inc. (BCDA)
is a Sell
Is BioCardia, Inc. a Buy or a Sell?
-
BioCardia, Inc. stock is rated a SellThe current BioCardia, Inc. [BCDA] share price is $1.27. The Score for BCDA is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.